Inhibition of Wb-iPGM using analogues of Clorsulon and co-administration with DEC for bancroftian filariasis treatment
نویسندگان
چکیده
Wucherria bancrofti (Wb) is the main causative agent of Filariasis. Lymphatic Filariasis (LF) is a disabling, disfiguring, and a poverty promoting disease which is caused by the parasitic filarial nematode worms. The identification of essential nematode genes has shown that independent phosphoglycerate mutase (iPGM) is an excellent drug target against parasitic nematodes. In this current study, we have used our previously modeled structure of Wb-iPGM to inhibit the Embden Mayerhoff pathways of Wb using the Clorsulon and their analogues. Further, these analogues were scrutinized based on the pharmacokinetics and best complex were proposed to inhibit the Wb-iPGM enzyme. This current study provides an insight towards the process of design and development of novel drug target and their mode of interaction with the potent anthelmintic drugs.
منابع مشابه
Current Evidence on the Use of Antifilarial Agents in the Management of Bancroftian Filariasis
Many trials have explored the efficacy of individual drugs and drug combinations to treat bancroftian filariasis. This narrative review summarizes the current evidence for drug management of bancroftian filariasis. Diethylcarbamazine (DEC) remains the prime antifilarial agent with a well-established microfilaricidal and some macrofilaricidal effects. Ivermectin (IVM) is highly microfilaricidal ...
متن کاملSurveillance of imported bancroftian filariasis after two-year multiple-dose diethylcarbamazine treatment.
Myanmar migrants are at increased risk for nocturnally periodic Wuchereria bancrofti causing imported bancroftian filariasis. They have a significant influence on the effectiveness of diethylcarbamazine (DEC) mass treatment at the provincial level in the National Program to Eliminate Lymphatic Filariasis (PELF) during the fiscal years (FY) 2002-2006, in Thailand. Two oral doses of DEC 6 mg/kg a...
متن کاملA randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis.
The Global Program for Elimination of Lymphatic Filariasis calls for mass drug administration for endemic populations outside of sub-Saharan Africa with a single dose of diethylcarbamazine (DEC) and albendazole (Alb) annually for 4-6 years. Single-dose DEC/Alb dramatically reduces blood microfilaria (MF) counts, but most treated subjects fail to completely clear MF after a single dose. A more e...
متن کاملImplication of diethylcarbamazine induced morbidity and the role of cellular responses associated with bancroftian filariasis pathologies.
Pre and post-diethylcarbamazine treatment clinical expression, microfilaraemia prevalence and cellular responses were investigated in individuals in Tanga, Tanzania. Fifty-seven male individuals (aged = 15 years old) were identified for further studies on IL-4, IL-6, IL-8. IFN-gamma, IL-beta, TNF-alpha and nitric oxide in plasma and hydrocoele fluid. Microfilarial prevalence in the examined ind...
متن کاملEstimation of different degrees of provocation by DEC (diethyl carbamazine citrate) medication in bancroftian filariasis in Vellore, Tamilnadu.
DEC in general has the power to bringout the filarial worms into the peripheral blood when administered. The provocative effect was observed in 86.8% of the mf positive cases. Optimum provocative effect was noticed in the age group above 12 years and there was no influence on sex. The maximum effect of provocation was seen at 60 min after the administration 2 mg/kg body weight DEC. The mf rate ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2014